DCTs, Digital Therapeutics to Make Further Headway in 2024, Say Experts
January 2, 2024
Decentralized trial (DCT) methods will continue to evolve in 2024 as a group effort led by the Tufts Center for the Study of Drug Development (CSDD) to gather/utilize DCT data for informing future protocol designs aims to deliver its first dataset in the first quarter. By the end of 2024, decentralization will have established itself as the new gold standard for trials, experts predict.